Efficacy and Safety of Catheter Ablation in Very Elderly Patients With Atrial Fibrillation: Short‐ To Mid‐Term Outcomes From a Multicenter Study
Journal of Arrhythmia · 2026-06 · 42 (3)
DOI: 10.1002/joa3.70356 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Arrhythmia, online erschienen am 14.05.2026. Verfasst von Takumi Tamura und 14 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine III Hamamatsu University School of Medicine Hamamatsu Japan. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Catheter ablation has become a cornerstone of atrial fibrillation (AF) treatment. The prevalence of AF increases with age. However, research on catheter ablation in very elderly patients (age ≥ 80 years) is limited. This study aimed to assess the efficacy and safety of catheter ablation in very elderly patients with AF.
Methods
We enrolled 150 very elderly patients (mean age, 82.2 ± 2.2 years, 84 men) who underwent catheter ablation for AF in 2018–2023. We assessed AF recurrence, periprocedural complications, and all‐cause mortality.
Results
One hundred (67%) patients had paroxysmal AF, and 136 (90.6%) underwent their first ablation for AF. At 2 years, the recurrence‐free survival rate was 85.8% (95% confidence interval [CI], 78.2%–94.2%) in paroxysmal AF and 63.6% (95% CI, 48.9%–82.6%) in persistent AF ( p = 0.024). Periprocedural complications occurred in 18 (12.0%) patients. The most common were bleeding events ( n = 9; 6.0%), followed by post‐ablation heart failure ( n = 7; 4.7%). In‐hospital death, embolism, gastroesophageal complications, and phrenic nerve paralysis did not occur in any cases. During the median follow‐up period of 527 days (interquartile range: 364–913 days), 11 patients (7.3%) died from causes unrelated to the catheter ablation procedures. Periprocedural complications were not associated with an increased risk of all‐cause mortality ( p = 0.475).
Conclusions
Catheter ablation demonstrates reasonable efficacy and safety in very elderly patients with AF.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine III Hamamatsu University School of Medicine Hamamatsu Japan.
- Department of Cardiology Hamamatsu Red Cross Hospital Hamamatsu Japan.
- Department of Cardiology Hamamatsu Medical Center Hamamatsu Japan.
- Department of Cardiology Seirei Hamamatsu General Hospital Hamamatsu Japan.
- Department of Cardiology Seirei Mikatahara General Hospital Hamamatsu Japan.
ORCID-Profile: Yoshihisa Naruse, Yutaro Kaneko, Ryosuke Takeuchi, Yuichiro Maekawa
Zitieren
APA
Tamura, T., Naruse, Y., Narumi, T., Tokonami, Y., Takazawa, Y., Ito, K., Kaneko, Y., Sano, M., Takeuchi, R., Hosoya, N., Muto, M., Henmi, R., Sugiura, R., Miyajima, K., & Maekawa, Y. (2026). Efficacy and Safety of Catheter Ablation in Very Elderly Patients With Atrial Fibrillation: Short‐ To Mid‐Term Outcomes From a Multicenter Study. Journal of Arrhythmia, 42(3). https://doi.org/10.1002/joa3.70356
Vancouver
Tamura T, Naruse Y, Narumi T, Tokonami Y, Takazawa Y, Ito K, et al. Efficacy and Safety of Catheter Ablation in Very Elderly Patients With Atrial Fibrillation: Short‐ To Mid‐Term Outcomes From a Multicenter Study. Journal of Arrhythmia. 2026;42(3). doi:10.1002/joa3.70356
BibTeX
@article{Tamura2026,
author = {Tamura, Takumi and Naruse, Yoshihisa and Narumi, Taro and Tokonami, Yuki and Takazawa, Yasukazu and Ito, Kazuki and Kaneko, Yutaro and Sano, Makoto and Takeuchi, Ryosuke and Hosoya, Natsuko and Muto, Masahiro and Henmi, Ryuta and Sugiura, Ryo and Miyajima, Keisuke and Maekawa, Yuichiro},
title = {Efficacy and Safety of Catheter Ablation in Very Elderly Patients With Atrial Fibrillation: Short‐ To Mid‐Term Outcomes From a Multicenter Study},
journal = {Journal of Arrhythmia},
year = {2026},
volume = {42},
number = {3},
doi = {10.1002/joa3.70356}
}
EUVIMED